MedTrace Logo

Prevention of Nicotine Abstinence in Critically Ill Patients After Major Surgery

NCT03847155 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 52

Last updated 2021-02-09

No results posted yet for this study

Summary

The primary objective of this study is to determine whether the application of transdermal nicotine patches in critically ill patients after major surgery with nicotine abstinence condition is associated with a lower incidence of delirium.

Conditions

  • Nicotine Dependence

Interventions

DRUG

Nicotine patch

The patients will receive a nicotine patch for the period of a maximum of 7 days.

OTHER

Placebo patch

The patients will receive a placebo patch for the period of a maximum of 7 days.

Sponsors & Collaborators

  • University Hospital Ostrava

    lead OTHER

Principal Investigators

  • Jan Neiser, MD · University Hospital Ostrava

Study Design

Allocation
RANDOMIZED
Purpose
PREVENTION
Masking
TRIPLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2015-09-23
Primary Completion
2021-01-31
Completion
2021-02-08

Countries

  • Czechia

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03847155 on ClinicalTrials.gov